Redsense Medical

As communicated on December 2, 2022, Redsense Medical secured the company's largest order to date valued at MSEK 15.20 from one of the company's US distributors. A partial delivery valued around MSEK 4.75 was shipped and invoiced in December 2022. The balance of the order is planned for delivery in Q1 2023 and the company is working with the distributor on the logistics of the order.

"We are very pleased with the collaboration with our supply chain partners regarding the delivery plan and the prompt shipment of this part delivery of the larger order. With this delivery, we secure a strong finish of 2022 and look forward to keeping the momentum and an excellent start of 2023. As always, we continue our focus to promote and provide patient safety during hemodialysis" says Pontus Nobréus CEO of Redsense Medical AB.